ATE287947T1 - Orale immunisierung durch verwendung von transgenen pflanzen - Google Patents

Orale immunisierung durch verwendung von transgenen pflanzen

Info

Publication number
ATE287947T1
ATE287947T1 AT95940519T AT95940519T ATE287947T1 AT E287947 T1 ATE287947 T1 AT E287947T1 AT 95940519 T AT95940519 T AT 95940519T AT 95940519 T AT95940519 T AT 95940519T AT E287947 T1 ATE287947 T1 AT E287947T1
Authority
AT
Austria
Prior art keywords
plants
plant
transgenic
animals
transgenic plants
Prior art date
Application number
AT95940519T
Other languages
English (en)
Inventor
Charles J Arntzen
Hugh S Mason
Tariq A Haq
John D Clements
Original Assignee
Texas A & M Univ Sys
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys, Univ Tulane filed Critical Texas A & M Univ Sys
Application granted granted Critical
Publication of ATE287947T1 publication Critical patent/ATE287947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT95940519T 1994-10-24 1995-10-24 Orale immunisierung durch verwendung von transgenen pflanzen ATE287947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32871694A 1994-10-24 1994-10-24
PCT/US1995/013376 WO1996012801A1 (en) 1994-10-24 1995-10-24 Oral immunization with transgenic plants

Publications (1)

Publication Number Publication Date
ATE287947T1 true ATE287947T1 (de) 2005-02-15

Family

ID=23282114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95940519T ATE287947T1 (de) 1994-10-24 1995-10-24 Orale immunisierung durch verwendung von transgenen pflanzen

Country Status (11)

Country Link
US (1) US6194560B1 (de)
EP (1) EP0793717B1 (de)
JP (1) JPH10507916A (de)
AT (1) ATE287947T1 (de)
AU (1) AU691707B2 (de)
CA (1) CA2203679C (de)
DE (1) DE69533964T2 (de)
ES (1) ES2235176T3 (de)
MX (1) MX9703017A (de)
NZ (1) NZ297142A (de)
WO (1) WO1996012801A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
WO1997010347A1 (en) * 1995-09-15 1997-03-20 Howard John A Expression cassettes and methods for delivery of animal vaccines
US6261561B1 (en) 1996-04-19 2001-07-17 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
US6942861B2 (en) 1996-04-19 2005-09-13 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
FR2748480B1 (fr) * 1996-05-09 1998-09-04 Biocem Plantes transgeniques exprimant la glycoproteine g de la rage, et glycoproteines ainsi obtenues
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
WO1998048046A2 (en) * 1997-04-22 1998-10-29 Bavarian Nordic Research Institute A/S Taqmantm-pcr for the detection of pathogenic e. coli strains
US20050241024A1 (en) * 1997-10-07 2005-10-27 Langridge William H Transgenic plant-based vaccines
US7422747B2 (en) * 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US6777546B2 (en) 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use
WO2000037609A2 (en) * 1998-12-22 2000-06-29 Boyce Thompson Institute For Plant Research At Cornell Orally immunogenic bacterial enterotoxins expressed in transgenic plants
MXPA01006491A (es) * 1998-12-23 2003-06-06 Thompson Boyce Plant Res Expresion de antigenos de superficie de hepatitis b inmunogenicos en plantas transgenicas.
EP1246929A2 (de) * 2000-01-14 2002-10-09 Prodigene, Inc. Methoden und zusammensetzungen zur immunisierung von tieren
AUPQ520800A0 (en) * 2000-01-21 2000-02-17 Alfred Hospital Prime-boost vaccination strategy
EP1254156A4 (de) * 2000-01-27 2003-05-21 Univ Loma Linda Auf transgene pflanzen basierender impstoff
US7081567B2 (en) * 2000-12-03 2006-07-25 Lexun Xue Transgenic dunaliella salina as a bioreactor
ITRM20010332A1 (it) * 2001-06-11 2002-12-11 Ist Superiore Sanita Vaccini a subunita' e procedimenti per la loro produzione.
US20040003432A1 (en) * 2002-05-06 2004-01-01 Pharmacia Corporation Production of hexosamines and uses thereof
WO2004003143A2 (en) * 2002-06-26 2004-01-08 Advanced Bionutrition Corporation Viruses and virus-like particles for multiple antigen and target display
ES2224792B1 (es) * 2002-06-28 2007-02-16 Era Plantech, S.L. Produccion de peptidos y proteinas por acumulacion de cuerpos proteicos derivados de reticulos endoplasmico en plantas.
BR0314088A (pt) * 2002-08-27 2005-07-19 Dow Agrosciences Llc Uso de toxina de escherichia coli lábil ao calor como um adjuvante em pássaros e aves domésticas
US20040117874A1 (en) * 2002-10-15 2004-06-17 Jianjun Yang Methods for accumulating translocated proteins
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
US20040248798A1 (en) 2003-02-14 2004-12-09 Peter Sutovsky Contraceptive methods and compositions related to proteasomal interference
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
US7951557B2 (en) 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
AU2004235813B2 (en) * 2003-05-05 2010-07-29 Boyce Thompson Institute For Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
NZ542933A (en) * 2003-05-05 2009-08-28 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
EP1522585A1 (de) * 2003-10-09 2005-04-13 Plant Research International B.V. Chimäre Trägermoleküle zur Produktion von Impfstoffen, die durch die Schleimhaut aufgenommen werden
JP4898432B2 (ja) 2004-05-31 2012-03-14 北里第一三共ワクチン株式会社 遺伝子組換え植物による抗原虫病経口ワクチン
CA2579882C (en) 2004-09-10 2012-07-17 Asahi Glass Company, Limited Edible vaccine
US7723570B2 (en) 2004-10-12 2010-05-25 Soymeds, Inc. Edible vaccines expressed in soybeans
EP1685848A1 (de) * 2005-01-26 2006-08-02 Plant Research International B.V. Orale Impfstoffe für Fische
WO2007055894A2 (en) 2005-11-04 2007-05-18 Dow Agrosciences Llc Preparation of vaccine master cell lines using recombinant plant suspension cultures
AU2006335256B2 (en) 2005-11-22 2012-10-18 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
WO2007111500A1 (en) * 2006-03-27 2007-10-04 Plant Research International B.V. Immunization with transgenic mushrooms
EP2150608B1 (de) 2007-05-07 2017-11-29 Protalix Ltd. Grossvolumiger einweg-bioreaktor
US20110014231A1 (en) * 2007-11-05 2011-01-20 Mor Research Applications Ltd Anti-measles cancer immunotherapy
KR101540496B1 (ko) 2008-05-02 2015-08-25 이데미쓰 고산 가부시키가이샤 세균 독소 백신
WO2010106997A1 (ja) * 2009-03-19 2010-09-23 株式会社カネカ 核酸の検出方法及びキット、デバイス
KR101339703B1 (ko) * 2012-07-23 2013-12-11 전북대학교산학협력단 식물을 이용한 재조합 돼지 유행성 설사병 바이러스 (ｐｅｄｖ) 백신의 제조 방법 및 그에 따른 ｐｅｄｖ 백신
US20160213766A1 (en) * 2013-09-23 2016-07-28 Ventria Bioscience, Inc. OspA Fusion Protein for Vaccination against Lyme Disease
JP6523966B2 (ja) 2013-11-26 2019-06-05 出光興産株式会社 大腸菌性下痢症の予防
JP2025522293A (ja) * 2022-05-23 2025-07-15 バクスディグム カンパニー，リミティド ウイルスヌクレオカプシドを用いた五量体毒素タンパク質ベースの標的タンパク質融合五量体製造プラットフォーム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380831A (en) * 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
IL91525A0 (en) 1988-09-06 1990-04-29 Univ Washington Transgenic plants,pharmaceutical compositions containing the same and methods for the preparation thereof
FR2636842B1 (fr) * 1988-09-27 1994-06-10 Liege Universite Etat Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
UA48104C2 (uk) * 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
TW261517B (de) * 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
EP0618813B1 (de) * 1992-09-16 2002-01-09 The University Of Tennessee Research Corporation Antigene des hybriden m-proteins und träger für gruppe a streptokokkenimpfstoff

Also Published As

Publication number Publication date
WO1996012801A1 (en) 1996-05-02
ES2235176T3 (es) 2005-07-01
US6194560B1 (en) 2001-02-27
MX9703017A (es) 1997-10-31
DE69533964D1 (de) 2005-03-03
AU691707B2 (en) 1998-05-21
EP0793717A1 (de) 1997-09-10
EP0793717B1 (de) 2005-01-26
CA2203679A1 (en) 1996-05-02
JPH10507916A (ja) 1998-08-04
NZ297142A (en) 2001-09-28
DE69533964T2 (de) 2006-03-30
EP0793717A4 (de) 1998-11-25
CA2203679C (en) 2010-08-17
AU4194096A (en) 1996-05-15

Similar Documents

Publication Publication Date Title
DE69533964D1 (de) Orale immunisierung durch verwendung von transgenen pflanzen
ATE390933T1 (de) Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
BRPI0410340A (pt) vetores e células para preparar composições imunoprotetoras derivadas de plantas transgênicas
NO913518L (no) Vaksiner for ikke typebestembar haemophilus influenzae.
NO20011586D0 (no) Nye metoder for terapeutisk vaksinasjon
EP0658118A4 (de) Impfstoffe gegen neisseria meningitidis gruppe c.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
ATE85622T1 (de) Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
DE68928432D1 (de) Legionellosis-impfstoffe und verfahren zur herstellung
ES2054657T3 (es) Nuevos oligosacaridos y su metodo de preparacion.
FI102616B1 (fi) Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
WO2001095933A3 (en) Immunization through oral administration of a vaccine with an edible product
Somani et al. Reimmunization after allogeneic bone marrow transplantation
NO20053328L (no) Immunisering av fisk med uttrykte proteiner i planteceller.
ATE107516T1 (de) Pasteurella-impfstoff.
EP0652769A1 (de) Impfstoffe gegen MetazoonParasiten.
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
DK46988D0 (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
SE8205247L (sv) Fiskvacciner
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor
CN100411685C (zh) 动物狂犬病病毒糖/核蛋白“二价”dna疫苗
Kaattari et al. The role of polyclonal activation in antibody production by salmonid lymphocytes Invitro
DE60033562D1 (de) Künstliche promotoren zür protein expression in pflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0793717

Country of ref document: EP